Pouloudi, D.; Manou, M.; Sarantis, P.; Tsoukalas, N.; Tsourouflis, G.; Dana, E.; Karamouzis, M.V.; Klijanienko, J.; Theocharis, S.
Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors. Diagnostics 2021, 11, 517.
https://doi.org/10.3390/diagnostics11030517
AMA Style
Pouloudi D, Manou M, Sarantis P, Tsoukalas N, Tsourouflis G, Dana E, Karamouzis MV, Klijanienko J, Theocharis S.
Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors. Diagnostics. 2021; 11(3):517.
https://doi.org/10.3390/diagnostics11030517
Chicago/Turabian Style
Pouloudi, Despoina, Maria Manou, Panagiotis Sarantis, Nikolaos Tsoukalas, Gerasimos Tsourouflis, Eougken Dana, Michalis V. Karamouzis, Jerzy Klijanienko, and Stamatios Theocharis.
2021. "Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors" Diagnostics 11, no. 3: 517.
https://doi.org/10.3390/diagnostics11030517
APA Style
Pouloudi, D., Manou, M., Sarantis, P., Tsoukalas, N., Tsourouflis, G., Dana, E., Karamouzis, M. V., Klijanienko, J., & Theocharis, S.
(2021). Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors. Diagnostics, 11(3), 517.
https://doi.org/10.3390/diagnostics11030517